[Effect of angiotensin II on transforming growth factor beta-induced fibroblast proliferation in human skin].
Hongwei Liu, Biao Cheng, Xiaobing Fu
Abstract
Hongwei Liu, Biao Cheng, Xiaobing Fu
Abstract
OBJECTIVE: To observe the effect of angiotensin II (Ang II) or/and transforming growth factor beta (TGF-beta) on human skin fibroblast proliferation, and to explore the possible signaling mechanism involved in their actions. METHODS: Cultured human skin fibroblasts were treated with different concentrations of Ang II (1 x 10(-10), 1 x 10(-9), 1 x 10(-8) and 1 x 10(-7) mol/L) , TGF-beta(0.1, 1.0 and 10.0 ng/ml), and 1 x 10(-10) mol/L Ang II + 0.1 ng/ml TGF-beta, respectively. The cell proliferation was determined by 3H-thymidine (3H-TdR) incorporation. The phosphorylation of extracellular signal-regulated kinases (ERK) was detected by Western blot. RESULTS: Ang II at 1 x 10(-9), 1 x 10(-8), 1 x 10(-7) mol/L or TGF-beta at 1.0, 10.0 ng/ml increased 3H-TdR incorporation into cultured skin fibroblasts dose-dependently. Ang II and TGF-beta at lower doses (1 x 10(-10) mol/L and 0.1 ng/ml, respectively) did not affect 3H-TdR incorporation into fibroblasts (P>0.05), whereas co-administration of both Ang II and TGF-beta at these doses significantly increased 3H-TdR incorporation into fibroblasts (P<0.05). Ang II at 1 x 10(-7) mol/L or TGF-beta at 10.0 ng/ml significantly increased ERK phosphorylation of fibroblasts after stimulation (P<0.01). Smaller doses of Ang II (1 x 10(-10) mol/L) or TGF-beta (0.1 ng/ml) did not influence ERK phosphorylation of fibroblasts, whereas co-administration of Ang II and TGF-beta at these doses significantly enhanced ERK phosphorylation (P<0.05). Total protein levels of ERK did not differ at different doses. CONCLUSION: These results indicate that Ang II and TGF-beta synergistically increase skin fibroblast proliferation, which is at least partly via enhancement of ERK activity.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To observe the effect of angiotensin II (Ang II) or/and transforming growth factor beta (TGF-beta) on human skin fibroblast proliferation, and to explore the possible signaling mechanism involved in their actions. METHODS: Cultured human skin fibroblasts were treated with different concentrations of Ang II (1 x 10(-10), 1 x 10(-9), 1 x 10(-8) and 1 x 10(-7) mol/L) , TGF-beta(0.1, 1.0 and 10.0 ng/ml), and 1 x 10(-10) mol/L Ang II + 0.1 ng/ml TGF-beta, respectively. The cell proliferation was determined by 3H-thymidine (3H-TdR) incorporation. The phosphorylation of extracellular signal-regulated kinases (ERK) was detected by Western blot. RESULTS: Ang II at 1 x 10(-9), 1 x 10(-8), 1 x 10(-7) mol/L or TGF-beta at 1.0, 10.0 ng/ml increased 3H-TdR incorporation into cultured skin fibroblasts dose-dependently. Ang II and TGF-beta at lower doses (1 x 10(-10) mol/L and 0.1 ng/ml, respectively) did not affect 3H-TdR incorporation into fibroblasts (P>0.05), whereas co-administration of both Ang II and TGF-beta at these doses significantly increased 3H-TdR incorporation into fibroblasts (P<0.05). Ang II at 1 x 10(-7) mol/L or TGF-beta at 10.0 ng/ml significantly increased ERK phosphorylation of fibroblasts after stimulation (P<0.01). Smaller doses of Ang II (1 x 10(-10) mol/L) or TGF-beta (0.1 ng/ml) did not influence ERK phosphorylation of fibroblasts, whereas co-administration of Ang II and TGF-beta at these doses significantly enhanced ERK phosphorylation (P<0.05). Total protein levels of ERK did not differ at different doses. CONCLUSION: These results indicate that Ang II and TGF-beta synergistically increase skin fibroblast proliferation, which is at least partly via enhancement of ERK activity.
Key concepts: Angiotensin II, Endocrinology, Internal medicine, Fibroblast, Transforming growth factor, Chemistry, Stimulation, Extracellular